Assessing gait using a smartphone application
Validity and Reliability of a Smartphone Application for Gait Assessment
Istanbul University - Cerrahpasa · NCT06157749
This study is testing a smartphone app for measuring walking patterns to see if it works as well as traditional methods for healthy young adults.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 34 (estimated) |
| Ages | 18 Years to 26 Years |
| Sex | All |
| Sponsor | Istanbul University - Cerrahpasa (other) |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06157749 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the Gait-Analyzer smartphone application compared to traditional 3D computerized gait analysis. Healthy participants aged 18 to 26 will be recruited and divided into two groups to undergo both types of gait analysis. The aim is to determine the validity and reliability of the smartphone application in assessing human gait, which is crucial for clinical decision-making. By leveraging the accessibility of smartphone technology, the study seeks to address the limitations of conventional gait analysis methods.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy individuals aged 18 to 26 with a normal body mass index.
Not a fit: Patients with lower extremity rotational problems, recent injuries, or any neurological or musculoskeletal disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more accessible and cost-effective method for gait analysis in clinical settings.
How similar studies have performed: While the use of smartphone applications for gait analysis is emerging, this specific comparison with the gold standard has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 26 years. * Body Mass Index (BMI) within normal limits (18.5-24.9 kg/m2) Exclusion Criteria: * Presence of lower extremity rotational problems (such as high femoral anteversion, internal tibial torsion, metatarsus adductus). * History of Botulinum Toxin Type A (BoNT-A) application or surgery within the last 6 months. * History of lower extremity injury within the last 6 months. * Leg length discrepancy. * Presence of third-degree pes planus. * Any neurological, rheumatic, musculoskeletal, metabolic, or connective tissue diseases. * History of pain, deformity, or surgery related to the vertebral column and upper extremities. * Presence of cognitive, mental, and/or severe psychiatric disorders
Where this trial is running
Istanbul
- Acibadem Mehmet Ali Aydinlar University — Istanbul, Turkey (Türkiye) (RECRUITING)
Study contacts
- Principal investigator: Ayşenur Erekdağ, MSc — Bezmialem Vakif University
- Study coordinator: Ayşenur Erekdağ, MSc
- Email: aysenurerekdag@gmail.com
- Phone: 05548959013
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Health, Subjective, 3D Computerized Gait Analysis, Gait-Analyzer, Gait Analysis, Smartphone Application